about
Evolutionary landscape of the Mycobacterium tuberculosis complex from the viewpoint of PhoPR: implications for virulence regulation and application to vaccine developmentESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the questionControl of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoPThe virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosisHigh content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodelingMycobacterium smegmatis displays the Mycobacterium tuberculosis virulence-related neutral red character when expressing the Rv0577 gene.The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis.Novel streptomycin resistance gene from Mycobacterium fortuitum.PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence.MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages.Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from SpainDeciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237.The transcriptional regulatory network of Mycobacterium tuberculosisBim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis.Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulatorRevisiting the evolution of Mycobacterium bovisA specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 componentIS-seq: a novel high throughput survey of in vivo IS6110 transposition in multiple Mycobacterium tuberculosis genomes.Attenuated Mycobacterium tuberculosis SO2 vaccine candidate is unable to induce cell death.Mapping IS6110 in high-copy number Mycobacterium tuberculosis strains shows specific insertion points in the Beijing genotype.Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from VenezuelaEpidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches.IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaksRapid test for identification of a highly transmissible Mycobacterium tuberculosis Beijing strain of sub-Saharan originGranzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoThe dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?Detection of a Putative TetR-Like Gene Related to Mycobacterium bovis BCG Growth in Cholesterol Using a gfp-Transposon Mutagenesis System.A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra.MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum.Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosis strainGlobal study of IS6110 in a successful Mycobacterium tuberculosis strain: clues for deciphering its behavior and for its rapid detection.The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesIn-depth analysis of the genome sequence of a clinical, extensively drug-resistant Mycobacterium bovis strain.Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines.Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
P50
Q26778612-0D6FADDA-576E-4119-84F1-3DA381A87EDCQ27011691-57919854-9A74-49A8-AC50-E5262DC1BEACQ28486372-D2892A80-8D01-4346-9EC2-42470AB3F2AEQ28486587-6C89B801-EC94-403E-A2E8-76BF41128C3FQ28486868-C26B761A-149E-4B71-9B40-9B37BF54FB95Q31051577-6E9FBF0A-1A64-4287-B668-AD129EE6D5D7Q31161909-5215CB26-1069-4E86-B24D-ACD41C2F4665Q33256453-D192A629-11F6-4120-81E4-7389E17C7319Q33346189-12D34413-FD67-4DB5-A0FD-FDF36C75ECE6Q33430265-0FC3112D-BB76-47FB-B5A2-F978F7DE43FAQ33707510-B1B7A273-A9A6-4898-B061-0DB7AD7BE3ACQ33752939-0405728C-859D-4044-A365-DEDDB1C05BA8Q33800256-9E18C8B2-2D90-4715-8DAF-6333E8A25560Q33983129-82988831-3DB7-4A91-94CD-FCA2AB491D44Q34007843-9376E04E-034A-4559-B7FC-8BE577E8EA92Q34025554-8AC40064-31AF-41E5-8BEB-D71F3A2B5D1FQ34048389-1A92CDB3-D0AD-4A49-86EA-1E2CBC9894EFQ34059004-3AFBC3B8-E671-43B6-A148-07B043ED4730Q34306273-44459D84-5038-4616-BD5E-6A2492223EE8Q34428364-43F079C1-F871-4DA9-883B-E57E720FDE55Q34783118-D4CD61AD-03D6-4D9A-92A3-CDDCB8D9CDC3Q35107425-04F173E5-FE49-4659-8277-F1D0EFE8E096Q35536046-A4B6BF19-83BE-4072-ACBB-8454CF402B5DQ35551848-F5F4DE79-4A30-4EC7-9D86-F3D8DF0EDB5AQ35689004-19B3839B-66B0-4D77-B66D-58B871785383Q35982800-2F4185F3-4EAB-44F0-8A5E-13D5920BC0E2Q36182503-43C48121-696C-4B10-8EB8-518B967AF9C4Q36315660-EF0A841C-2293-4DBD-93B7-D4C5610FBA51Q36452856-ACBD6833-93A2-4DD5-9137-CB8199A42685Q36504099-828D3F98-F5A9-4BA2-A3F0-E631FBE77FFFQ36832457-1C7BAEE6-4307-4DB5-99BF-64C883472083Q37131946-C5BBEAED-8026-43A5-AC07-9AC88BC3CA1EQ37470358-5CC8D882-79DF-45D7-9B95-976A23621073Q38444585-4B4CAC90-7B29-481A-8AF3-AC3ECA74F080Q38447962-DA511789-B4EB-4C50-8839-56DAF4090F58Q38529413-D2D6EB1D-DA2E-48AC-B8AB-E855E4D05C65Q38828575-43AC83C7-2F00-4C69-9CBF-75DFBAFA707EQ38847175-4BE67BD9-7A38-49A0-9D36-560FE6D4F8E8Q38849791-2297D2FE-5CA5-46A7-917D-87CA2C5CEDADQ38886409-DD0FCD1D-EAC9-44EC-A525-2238FF302A3D
P50
description
researcher
@en
հետազոտող
@hy
name
Carlos Martín
@ast
Carlos Martín
@en
Carlos Martín
@es
Carlos Martín
@nl
Carlos Martín
@sl
type
label
Carlos Martín
@ast
Carlos Martín
@en
Carlos Martín
@es
Carlos Martín
@nl
Carlos Martín
@sl
prefLabel
Carlos Martín
@ast
Carlos Martín
@en
Carlos Martín
@es
Carlos Martín
@nl
Carlos Martín
@sl
P106
P1153
7405842809
P21
P31
P496
0000-0003-2993-5478